Clinical trial

ECC5004 RBA FE Study in Healthy Participants

NCT06268145

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-02-06

PhasePHASE1

Study timeline

Study start (actual)2024-02-06Date precision: day

Registry last updated2024-07-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

ECC5004DRUG

Sponsors & collaborators

Eccogenelead sponsor

Mapped research locations

AnaheimCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06268145 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.